These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 31399965)
21. Cinacalcet attenuates the renal endothelial-to-mesenchymal transition in rats with adenine-induced renal failure. Wu M; Tang RN; Liu H; Xu M; Pan MM; Liu BC Am J Physiol Renal Physiol; 2014 Jan; 306(1):F138-46. PubMed ID: 24154694 [TBL] [Abstract][Full Text] [Related]
22. Blocking protein phosphatase 2A signaling prevents endothelial-to-mesenchymal transition and renal fibrosis: a peptide-based drug therapy. Deng Y; Guo Y; Liu P; Zeng R; Ning Y; Pei G; Li Y; Chen M; Guo S; Li X; Han M; Xu G Sci Rep; 2016 Jan; 6():19821. PubMed ID: 26805394 [TBL] [Abstract][Full Text] [Related]
24. Progenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition. Chen CL; Chou KJ; Fang HC; Hsu CY; Huang WC; Huang CW; Huang CK; Chen HY; Lee PT Stem Cell Res Ther; 2015 Dec; 6():239. PubMed ID: 26631265 [TBL] [Abstract][Full Text] [Related]
25. Netrin-1 attenuates the progression of renal dysfunction by blocking endothelial-to-mesenchymal transition in the 5/6 nephrectomy rat model. Bai J; Hao J; Zhang X; Cui H; Han J; Cao N BMC Nephrol; 2016 May; 17(1):47. PubMed ID: 27176224 [TBL] [Abstract][Full Text] [Related]
26. New Therapies for the Treatment of Renal Fibrosis. Liu F; Zhuang S Adv Exp Med Biol; 2019; 1165():625-659. PubMed ID: 31399988 [TBL] [Abstract][Full Text] [Related]
27. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells. Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031 [TBL] [Abstract][Full Text] [Related]
28. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis. Chang FC; Chou YH; Chen YT; Lin SL J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594 [TBL] [Abstract][Full Text] [Related]
29. Endothelial to Mesenchymal Transition in Pulmonary Vascular Diseases. Yun E; Kook Y; Yoo KH; Kim KI; Lee MS; Kim J; Lee A Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33371458 [TBL] [Abstract][Full Text] [Related]
30. Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation. Yuan Q; Tan RJ; Liu Y Adv Exp Med Biol; 2019; 1165():253-283. PubMed ID: 31399969 [TBL] [Abstract][Full Text] [Related]
31. Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury. Wang YY; Jiang H; Pan J; Huang XR; Wang YC; Huang HF; To KF; Nikolic-Paterson DJ; Lan HY; Chen JH J Am Soc Nephrol; 2017 Jul; 28(7):2053-2067. PubMed ID: 28209809 [TBL] [Abstract][Full Text] [Related]
32. Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction. Cho JG; Lee A; Chang W; Lee MS; Kim J Front Immunol; 2018; 9():294. PubMed ID: 29515588 [TBL] [Abstract][Full Text] [Related]
33. Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation. Bijkerk R; de Bruin RG; van Solingen C; van Gils JM; Duijs JM; van der Veer EP; Rabelink TJ; Humphreys BD; van Zonneveld AJ Kidney Int; 2016 Jun; 89(6):1268-80. PubMed ID: 27165825 [TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein A1 Inhibits the TGF-β1-Induced Endothelial-to-Mesenchymal Transition of Human Coronary Artery Endothelial Cells. Feng J; Zhang J; Jackson AO; Zhu X; Chen H; Chen W; Gui Q; Yin K Cardiology; 2017; 137(3):179-187. PubMed ID: 28434000 [TBL] [Abstract][Full Text] [Related]
35. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3. Sharma V; Dogra N; Saikia UN; Khullar M Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848 [TBL] [Abstract][Full Text] [Related]
36. Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy. Huuskes BM; Wise AF; Cox AJ; Lim EX; Payne NL; Kelly DJ; Samuel CS; Ricardo SD FASEB J; 2015 Feb; 29(2):540-53. PubMed ID: 25395452 [TBL] [Abstract][Full Text] [Related]
37. A small population of liver endothelial cells undergoes endothelial-to-mesenchymal transition in response to chronic liver injury. Ribera J; Pauta M; Melgar-Lesmes P; Córdoba B; Bosch A; Calvo M; Rodrigo-Torres D; Sancho-Bru P; Mira A; Jiménez W; Morales-Ruiz M Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G492-G504. PubMed ID: 28798084 [TBL] [Abstract][Full Text] [Related]
38. Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions. Pérez L; Muñoz-Durango N; Riedel CA; Echeverría C; Kalergis AM; Cabello-Verrugio C; Simon F Cytokine Growth Factor Rev; 2017 Feb; 33():41-54. PubMed ID: 27692608 [TBL] [Abstract][Full Text] [Related]
39. Instructive Role of the Microenvironment in Preventing Renal Fibrosis. Matsumoto K; Xavier S; Chen J; Kida Y; Lipphardt M; Ikeda R; Gevertz A; Caviris M; Hatzopoulos AK; Kalajzic I; Dutton J; Ratliff BB; Zhao H; Darzynkiewicz Z; Rose-John S; Goligorsky MS Stem Cells Transl Med; 2017 Mar; 6(3):992-1005. PubMed ID: 28297566 [TBL] [Abstract][Full Text] [Related]
40. TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Pardali E; Sanchez-Duffhues G; Gomez-Puerto MC; Ten Dijke P Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]